BRAIN and NERVE－神経研究の進歩72巻10号

2020年10月発行

特集 COVID-19—脳神経内科医が診るための最新知識

COVID-19流行期間における神経筋疾患に対するNPPV療法

著者： 藤田裕明¹ 鈴木圭輔¹

所属機関： ¹獨協医科大学脳神経内科

ページ範囲：P.1085 - P.1089

文献概要

神経筋疾患患者の換気補助の第一選択として非侵襲的陽圧換気（NPPV）が用いられる。しかしNPPVの使用により定常的にエアロゾルが発生するため，NPPV使用者がSARS-CoV-2に感染している場合，または感染が疑われる場合，新型コロナウイルス感染症症状の有無にかかわらず周囲の感染リスクに留意すべきである。本稿では感染予防の観点から，SARS-CoV-2流行期間における在宅，入院中のNPPV使用上の注意点について解説する。

参考文献

1)Zubair AS, McAlpine LS, Gardin T, Farhadian S, Kuruvilla DE, et al: Neuropathogenesis and neurologic manifestations of the coronaviruses in the age of coronavirus disease 2019: a review. JAMA Neurol, 2020 May 29［doi: 10.1001/jamaneurol.2020.2065］

2)Zhu J, Zhong Z, Ji P, Li H, Li B, et al: Clinicopathological characteristics of 8697 patients with COVID-19 in China: a meta-analysis. Fam Med Community Health 8: e000406, 2020［doi: 10.1136/fmch-2020-000406］

3)Herman C, Mayer K, Sarwal A: Scoping review of prevalence of neurologic comorbidities in patients hospitalized for COVID-19. Neurology 95: 77-84, 2020

4)Anderson EL, Turnham P, Griffin JR, Clarke CC: Consideration of the aerosol transmission for COVID-19 and public health. Risk Anal 40: 902-907, 2020

5)Ishikawa Y, Miura T, Ishikawa Y, Aoyagi T, Ogata H, et al: Duchenne muscular dystrophy: survival by cardio-respiratory interventions. Neuromuscul Disord 21: 47-51, 2011

6)Markström A, Sundell K, Lysdahl M, Andersson G, Schedin U, et al: Quality-of-life evaluation of patients with neuromuscular and skeletal diseases treated with noninvasive and invasive home mechanical ventilation. Chest 122: 1695-1700, 2002

7)Bushby K, Finkel R, Birnkrant DJ, Case LE, Clemens PR, et al: Diagnosis and management of Duchenne muscular dystrophy, part 2: implementation of multidisciplinary care. Lancet Neurol 9: 177-189, 2010

8)Wang CH, Bonnemann CG, Rutkowski A, SejersenT, Bellini J, et al: Consensus statement on standard of care for congenital muscular dystrophies. J Child Neurol 25: 1559-1581, 2010

9)Hull J, Aniapravan R, Chan E, Chatwin M, Forton J, et al: British Thoracic Society guideline for respiratory management of children with neuromuscular weakness. Thorax 67(Suppl 1): i1-i40, 2012

10)Fowler RA, Guest CB, Lapinsky SE, Sibbald WJ, Louie M, et al: Transmission of severe acute respiratory syndrome during intubation and mechanical ventilation. Am J Respir Crit Care Med 169: 1198-1202, 2004

11)World Health Organization: Rational use of personal protective equipment (PPE) for coronavirus disease (COVID-19): interim guidance. 2020 March 19

12)Barker J, Oyefeso O, Koeckerling D, Mudalige NL, Pan D: COVID-19: community CPAP and NIV should be stopped unless medically necessary to support life. Thorax 75: 367, 2020［doi: 10.1136/thoraxjnl-2020-214890］

13)Miller R, Englund K: Transmission and risk factors of OF COVID-19. Cleve Clin J Med, 2020 May 14［doi: 10.3949/ccjm.87a.ccc029］

14)Tran K, Cimon K, Severn M, Pessoa-Silva CL, Conly J: Aerosol generating procedures and risk of transmission of acute respiratory infections to healthcare workers: a systematic review. PLOS ONE 7: e35797, 2012［doi: 10.1371/journal.pone.0035797］

15)van Doremalen N, Bushmaker T, Morris DH, Holbrook MG, Gamble A, et al: Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1. N Engl J Med 382: 1564-1567, 2020

16)American Academy of Sleep Medicine (AASM): Coronavirus FAQs: CPAP tips for sleep apnea patients. March 17 2020　https://aasm.org/coronavirus-covid-19-faqs-cpap-sleep-apnea-patients/（最終閲覧日: 2020年7月21日）

17)Krishnan V: COVID-19 and home positive airway pressure (PAP) therapy. Am J Respir Crit Care Med 201: 28-29, 2020

18)Solé G, Salort-Campana E, Pereon Y, Stojkovic T, Wahbi K, et al: Guidance for the care of neuromuscular patients during the COVID-19 pandemic outbreak from the French Rare Health Care for Neuromuscular Diseases Network. Rev Neurol (Paris) 176: 507-515, 2020

19)Baker JG, Sovani M: Case for continuing community NIV and CPAP during the COVID-19 epidemic. Thorax 75: 368, 2020［doi: 10.1136/thoraxjnl-2020-214913］

20)Public Health England: COVID-19: guidance for infection prevention and control in healthcare setings. version 1.0

21)Köhnlein T, Windisch W, Köhler D, Drabik A, Geiseler J, et al: Non-invasive positive pressure ventilation for the treatment of severe stable chronic obstructive pulmonary disease: a prospective, multicentre, randomised, controlled clinical trial. Lancet Respir Med 2: 698-705, 2014

22)Zou L, Ruan F, Huang M, Liang L, Huang H, et al: SARS-CoV-2 viral load in upper respiratory specimens of infected patients. N Engl J Med 382: 1177-1179, 2020

23)日本神経学会難病医療体制セクション: COVID-19に関連する筋ジストロフィー・重症心身障害児者・神経筋難病患者に対する呼吸ケアの注意点. 2020

24)Karamouzos V, Fligou F, Gogos C, Velissaris D: High flow nasal cannula oxygen therapy in adults with COVID-19 respiratory failure. A case report. Monaldi Arch Chest Dis 90: 2020［doi: 10.4081/monaldi.2020.1323］

25)Adir Y, Segol O, Kompaniets D, Ziso H, Yaffe Y, et al: COVID-19: minimising risk to healthcare workers during aerosol-producing respiratory therapy using an innovative constant flow canopy. Eur Respir J 55: 2001017, 2020［doi: 10.1183/13993003.01017-2020］

26)Lucchini A, Giani M, Isgrò S, Rona R, Foti G: The “helmet bundle” in COVID-19 patients undergoing non invasive ventilation. Intensive Crit Care Nurs 58: 102859, 2020［doi: 10.1016/j.iccn.2020.102859］

27)Li YC, Bai WZ, Hashikawa T: The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients. J Med Virol 92: 552-555, 2020

28)Wax RS, Christian MD: Practical recommendations for critical care and anesthesiology teams caring for novel coronavirus (2019-nCoV) patients. Can J Anaesth 67: 568-576, 2020